This trial is testing a new treatment for neuroblastoma that involves two courses of chemotherapy followed by stem cell rescue.
1 Primary · 3 Secondary · Reporting Duration: 3 years from first PBSC infusion
Experimental Treatment
12 Total Participants · 1 Treatment Group
Primary Treatment: Autologous Stem Cell Infusion · No Placebo Group · Phase 2
Age < 65 · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: